Different Metabolic Effects of Selective and Nonselective Beta-Blockers Rather Than Mere Heart Rate Reduction May Be the Mechanisms by Which Beta-Blockade Prevents Cardiovascular Events

Journal of the American College of Cardiology

Volumn 53, Issue 22, 2009, Pages 2105-

  Fragasso, Gabriele ^a   Cera, Michela ^a   Margonato, Alberto ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MOXONIDINE;

BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR DISEASE; ENDOTHELIUM; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART RATE; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; LETTER; LIPID BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; HEART RATE; HUMANS; HYPERTENSION;

EID: 65649110446     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.075     Document Type: Letter

References (7)

1. Bangalore S., Sawhney S., and Messerli F.H. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 52 (2008) 1482-1489
2. Podbregar M., and Voga G. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure. J Cardiac Fail 8 (2002) 369-378
3. Poole-Wilson P., Swedberg K., Cleland J., et al., Carvedilol or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362 (2003) 7-13
4. Wiltse C., Wright T., and MOXCON Investigators. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail 5 (2003) 659-666
5. Mobini R., Jansson P.A., Bergh C.H., Sharing Tang M., Waagstein F., and Andersson B. Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine. Clin Sci 110 (2006) 329-336
6. Lithell H.O. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14 (1991) 203-209
7. Celik T., Iyisoy A., Kursaklioglu H., et al. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients. J Hypertens 24 (2006) 591-596